featured
Impact of a Bone-Targeted Therapy Regimen on Skeletal-Related Events in Patients With MBC and Bone Metastasis Surviving Longer Than 2 Years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer